The weekly litigation news digest is live. Subscribe now

Maiwald competitive analysis

Explore patent oppositions filed by Maiwald against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 15, 2026
Patent NumberTitleApplicantOpposition Date
Dna-Pkcs Inhibitors For Increasing Genome Editing EfficiencyMAX PLANCK GESELLSCHAFT ZUR FRDERUNG DER WISSENSCHAFTEN EVDec 4, 2025
Methods And Compositions For Analyzing Nucleic AcidCLARET BIOSCIENCESep 18, 2025
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 26, 2025
Positioning And Identification Of Electronic Labels Using A CameraPRICERAug 22, 2025
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 20, 2025
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025
Liquid Allulose CompositionPFEIFER & LANGENJul 2, 2025
High-Purity Peg Lipids And Uses ThereofMODERNAJul 2, 2025
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025
Filtration Material Using Fiber Blends That Contain Strategically Shaped Fibers And/Or Charge Control AgentsMATIV LUXEMBOURGJun 11, 2025

Latest PTAB cases involving Maiwald

Discover the latest PTAB cases involving Maiwald, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Maiwald with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MAIWALD137 - - -
F HOFFMANN LA ROCHE16146 - -
MODERNA57542
NOVARTIS6423 - 21